Menu Close

Articles on Science and innovation for development

Displaying 1 - 20 of 166 articles

South African President Cyril Ramaphosa, Deputy president David Mabuza, Health Minister Dr Zweli Mkhize visiting the Aspen Pharmacare sterile manufacturing facility. Lulama Zenzile/Die Burger/Gallo Images via Getty Images

Why Africa’s push to make vaccines should look further than COVID-19

Vaccine manufacturing doesn’t come cheap. It depends heavily on support from developed countries. It also requires much more than relaxing intellectual property rights and a desire for vaccine equity.
A section of Quarry Road informal settlement in Durban after severe flooding in April 2019 where research was undertaken by local scientists. Catherine Sutherland

Reuters’ Hot List of climate scientists is geographically skewed: why this matters

Climate change science dominated by knowledge produced in the global North cannot address the particular challenges faced by those living in the global South.
Some of the dishes that make up the Square Kilometre Array’s radio telescope system. This kind of “blue skies” research can have great real-world value. MUJAHID SAFODIEN/AFP via Getty Images

COVID-19 budget pressures threaten curiosity-driven science. That’s a bad thing

The pandemic has underscored that the world requires agility for survival. That makes blue skies science, which encourages curiosity and nimble thinking, perhaps more important than ever.
Study shows that the Novavax vaccine is effective against the dominant variant of COVID-19 in South Africa. Jakub Porzycki/NurPhoto via Getty Images

Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?

The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.

Top contributors

More